NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Sunday 13 December 2009

Dottikon sales fall

H1 sales for Dottikon fell 42% to CHF45.3m. The company put this down to the elimination of redundant product lines and delayed commissioning of new apparatus groups. During the period Dottikon brought on-stream the expansion of its medium scale API separator capacity and large scale corrosion-resistant glass-lined steel and Hastelloy multipurpose reactor, low-temperature, and API separator capacity.
Dottikon

No comments: